Mesoblast (MEOBF) Total Current Liabilities (2017 - 2025)

Mesoblast (MEOBF) has disclosed Total Current Liabilities for 9 consecutive years, with $102.6 million as the latest value for Q2 2025.

  • Quarterly Total Current Liabilities rose 40.12% to $102.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $102.6 million through Jun 2025, up 40.12% year-over-year, with the annual reading at $102.6 million for FY2025, 40.12% up from the prior year.
  • Total Current Liabilities hit $102.6 million in Q2 2025 for Mesoblast, up from $73.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $102.6 million in Q2 2025 to a low of $42.0 million in Q2 2023.
  • Historically, Total Current Liabilities has averaged $72.7 million across 5 years, with a median of $73.2 million in 2024.
  • Biggest five-year swings in Total Current Liabilities: tumbled 45.51% in 2022 and later skyrocketed 74.46% in 2024.
  • Year by year, Total Current Liabilities stood at $94.3 million in 2021, then crashed by 45.51% to $51.4 million in 2022, then fell by 18.28% to $42.0 million in 2023, then surged by 74.46% to $73.2 million in 2024, then surged by 40.12% to $102.6 million in 2025.
  • Business Quant data shows Total Current Liabilities for MEOBF at $102.6 million in Q2 2025, $73.2 million in Q2 2024, and $42.0 million in Q2 2023.